Literature DB >> 7969512

Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block.

A Ohler1, G J Amos, E Wettwer, U Ravens.   

Abstract

Antiarrhythmic drugs with class III action are incriminated by "reverse use dependency" which implies preferential block of resting channels (Hondeghem and Snyders 1990). The purpose of the present study was to investigate the frequency dependence of the effects of four new antiarrhythmic compounds on action potential duration (APD) in guinea-pig papillary muscle and on delayed rectifier in guinea-pig ventricular myocytes in order to scrutinize the concept of reverse use dependency and to obtain evidence for drug-channel interaction. In guinea-pig papillary muscles, E-4031 (1-[2-(6-methyl-2-pyridyl)ethyl]-4- (4-methylsulfonyl-aminobenzoyl)piperidine), almokalant, dofetilide and tedisamil prolonged APD in a concentration-dependent manner. Drug-induced APD prolongation was not affected significantly by low rates of stimulation (0.2 to 0.5 Hz. In order to investigate whether drug-channel interaction takes places during rest, regular stimulation (1 Hz) was interrupted by three 30-min periods of quiescence. Drug was added at the beginning of the second period of rest, the third period was interposed at steady state of drug action. With E-4031 and dofetilide no change in shape of the first AP after the initial 30 min of drug exposure was observed as compared with pre-drug control, but regular stimulation was required for the full effect to develop. APD did not recover to pre-drug values after the third period of quiescence. With almokalant and tedisamil, however, the first APD after wash-in was already prolonged and the effects increased further with regular pacing. Only with almokalant but not with tedisamil did APD recover during rest.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969512     DOI: 10.1007/BF01258466

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.

Authors:  E Carmeliet
Journal:  J Pharmacol Exp Ther       Date:  1992-08       Impact factor: 4.030

2.  Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters.

Authors:  E Wettwer; G Scholtysik; A Schaad; H Himmel; U Ravens
Journal:  J Cardiovasc Pharmacol       Date:  1991-03       Impact factor: 3.105

3.  Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue.

Authors:  H C Strauss; J T Bigger; B F Hoffman
Journal:  Circ Res       Date:  1970-06       Impact factor: 17.367

4.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

5.  Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.

Authors:  L M Hondeghem; D J Snyders
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

6.  Tedisamil inactivates transient outward K+ current in rat ventricular myocytes.

Authors:  I D Dukes; M Morad
Journal:  Am J Physiol       Date:  1989-11

7.  Rate-related electrophysiologic effects of long-term administration of amiodarone on canine ventricular myocardium in vivo.

Authors:  K P Anderson; R Walker; T Dustman; R L Lux; P R Ershler; R E Kates; P M Urie
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

8.  Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action.

Authors:  M C Sanguinetti; N K Jurkiewicz; A Scott; P K Siegl
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

9.  Transient outward current in human and rat ventricular myocytes.

Authors:  E Wettwer; G Amos; J Gath; H R Zerkowski; J C Reidemeister; U Ravens
Journal:  Cardiovasc Res       Date:  1993-09       Impact factor: 10.787

10.  Quinidine delays IK activation in guinea pig ventricular myocytes.

Authors:  D M Roden; P B Bennett; D J Snyders; J R Balser; L M Hondeghem
Journal:  Circ Res       Date:  1988-05       Impact factor: 17.367

View more
  7 in total

Review 1.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Assessment of frequency dependency of the class III effects of almokalant: a study using programmed stimulation and recording of monophasic action potentials and ventricular paced QT intervals.

Authors:  B Darpö; O Almgren; R Bergstrand; S Franzén; N Edvardsson
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

3.  Effects of AWD 23-111, a new antiarrhythmic substance, on cardiac conduction and refractoriness.

Authors:  U Stark; G Stark; I Schwarzl; H Poppe; D Marx; M Decrinis; H A Tritthart
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

4.  Risperidone-induced action potential prolongation is attenuated by increased repolarization reserve due to concomitant block of I(Ca,L).

Authors:  Torsten Christ; Erich Wettwer; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-06-16       Impact factor: 3.000

5.  Increased Late Sodium Current Contributes to the Electrophysiological Effects of Chronic, but Not Acute, Dofetilide Administration.

Authors:  Xiaoliang S Qiu; Samuel Chauveau; Evgeny P Anyukhovsky; Tania Rahim; Ya-Ping Jiang; Erin Harleton; Steven J Feinmark; Richard Z Lin; Ruben Coronel; Michiel J Janse; Tobias Opthof; Tove S Rosen; Ira S Cohen; Michael R Rosen
Journal:  Circ Arrhythm Electrophysiol       Date:  2016-04

6.  Role of atrial fibrillation threshold evaluation on guiding treatment.

Authors:  Takeshi Shirayama
Journal:  Indian Pacing Electrophysiol J       Date:  2003-10-01

7.  Electrophysiological and structural remodeling in heart failure modulate arrhythmogenesis. 1D simulation study.

Authors:  Juan F Gomez; Karen Cardona; Lucia Romero; Jose M Ferrero; Beatriz Trenor
Journal:  PLoS One       Date:  2014-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.